Recent improvement in survival outcomes and reappraisal of prognostic factors in hepatoblastoma-Reference-Cited by-同舟云学术

Recent improvement in survival outcomes and reappraisal of prognostic factors in hepatoblastoma

Published:2021-05 Issue:10 Volume:10 Page:3261-3273
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Koh Kyung‐Nam¹^ORCID,Namgoong Jung‐Man²,Yoon Hee Mang³,Cho Young Ah³,Choi Se Hoon⁴,Shin Juhee¹,Kang Sung Han¹,Suh Jin Kyung¹,Kim Hyery¹,Oh Seak Hee⁵,Kim Kyung Mo⁵,Kim Dae Yeon²,Im Ho Joon¹

Affiliation:

1. Divison of Pediatric Hematology/Oncology Department of Pediatrics Asan Medical Center Children’s Hospital University of Ulsan College of Medicine Seoul Korea

2. Department of Pediatric Surgery Asan Medical Center Children’s Hospital University of Ulsan College of Medicine Seoul Korea

3. Department of Radiology and Research Institute of Radiology Asan Medical Center University of Ulsan College of Medicine Seoul Korea

4. Department of Thoracic and Cardiovascular Surgery Asan Medical Center University of Ulsan College of Medicine Seoul Korea

5. Divison of Pediatric Gastroenterology, Hepatology and Nutrition Department of Pediatrics Asan Medical Center Children’s Hospital University of Ulsan College of Medicine Seoul Korea

Funder

Asan Institute for Life Sciences, Asan Medical Center

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3897

Reference26 articles.

1. Hepatoblastoma and Pediatric Hepatocellular Carcinoma: An Update

2. Management of Hepatoblastoma in the Modern Era and Future Perspectives

3. The treatment of hepatoblastoma: Its evolution and the current status as per the SIOPEL trials